Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

The global Gene Editing Market was valued at $5.1 billion in 2022 and is projected to reach $16.2 billion by 2030, growing at ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

Genomic alterations in intraductal prostate cancer: Insights from the Genomic Umbrella Neoadjuvant study (GUNS) in high-risk localized disease. This is an ASCO Meeting Abstract from the 2025 ASCO ...

At the same time, the German group's Asklepios BioPharma (AskBio) unit has started recruiting patients for a phase 1b trial of its gene therapy for Parkinson's, another treatment with the ...

Copyright: © 2024 The Author(s). Published by Elsevier Ltd.

Germline DNA repair gene variants in patients under active surveillance for low-grade bladder cancer: Implications for risk stratification. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

This story was originally published by ProPublica. ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive its biggest stories as soon as they’re published.

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its ...